国务院关于修改《中华人民共和国对外合作开采海洋石油资源条例》决定
国务院
中华人民共和国国务院令
第607号
《国务院关于修改〈中华人民共和国对外合作开采海洋石油资源条例〉的决定》已经2011年9月21日国务院第173次常务会议通过，现予公布，自2011年11月1日起施行。
总理 温家宝
二○一一年九月三十日
国务院关于修改《中华人民共和国对外合作
开采海洋石油资源条例》的决定
国务院决定对《中华人民共和国对外合作开采海洋石油资源条例》作如下修改：
第十条修改为：“参与合作开采海洋石油资源的中国企业、外国企业，都应当依法纳税。”
本决定自2011年11月1日起施行。1989年1月1日经国务院批准财政部发布的《开采海洋石油资源缴纳矿区使用费的规定》同时废止。
自本决定施行之日起，中外合作开采海洋石油资源的中国企业和外国企业依法缴纳资源税，不再缴纳矿区使用费。但是，本决定施行前已依法订立的中外合作开采海洋石油资源的合同，在已约定的合同有效期内，继续依照当时国家有关规定缴纳矿区使用费，不缴纳资源税；合同期满后，依法缴纳资源税。
此外，对条文的个别文字作了修改。
《中华人民共和国对外合作开采海洋石油资源条例》根据本决定作相应的修改，重新公布。
中华人民共和国对外合作开采
海洋石油资源条例
（1982年1月30日国务院发布根据2001年9月23日《国务院关于修改〈中华人民共和国对外合作开采海洋石油资源条例〉的决定》第一次修订根据2011年1月8日《国务院关于废止和修改部分行政法规的决定》第二次修订根据2011年9月30日《国务院关于修改〈中华人民共和国对外合作开采海洋石油资源条例〉的决定》第三次修订）
第一章 总 则
第一条 为促进国民经济的发展，扩大国际经济技术合作，在维护国家主权和经济利益的前提下允许外国企业参与合作开采中华人民共和国海洋石油资源，特制定本条例。
第二条 中华人民共和国的内海、领海、大陆架以及其他属于中华人民共和国海洋资源管辖海域的石油资源，都属于中华人民共和国国家所有。
在前款海域内，为开采石油而设置的建筑物、构筑物、作业船舶，以及相应的陆岸油（气）集输终端和基地，都受中华人民共和国管辖。
第三条 中国政府依法保护参与合作开采海洋石油资源的外国企业的投资、应得利润和其他合法权益，依法保护外国企业的合作开采活动。
在本条例范围内，合作开采海洋石油资源的一切活动，都应当遵守中华人民共和国的法律、法令和国家的有关规定；参与实施石油作业的企业和个人，都应当受中国法律的约束，接受中国政府有关主管部门的检查、监督。
第四条 国家对参加合作开采海洋石油资源的外国企业的投资和收益不实行征收。在特殊情况下，根据社会公共利益的需要，可以对外国企业在合作开采中应得石油的一部分或者全部，依照法律程序实行征收，并给予相应的补偿。
第五条 国务院指定的部门依据国家确定的合作海区、面积，决定合作方式，划分合作区块；依据国家规定制定同外国企业合作开采海洋石油资源的规划；制定对外合作开采海洋石油资源的业务政策和审批海上油（气）田的总体开发方案。
第六条 中华人民共和国对外合作开采海洋石油资源的业务，由中国海洋石油总公司全面负责。
中国海洋石油总公司是具有法人资格的国家公司，享有在对外合作海区内进行石油勘探、开发、生产和销售的专营权。
中国海洋石油总公司根据工作需要，可以设立地区公司、专业公司、驻外代表机构，执行总公司交付的任务。
第七条 中国海洋石油总公司就对外合作开采石油的海区、面积、区块，通过组织招标，采取签订石油合同方式，同外国企业合作开采石油资源。
前款石油合同，经中华人民共和国商务部批准，即为有效。
中国海洋石油总公司采取其他方式运用外国企业的技术和资金合作开采石油资源所签订的文件，也应当经中华人民共和国商务部批准。
第二章 石油合同各方的权利和义务
第八条 中国海洋石油总公司通过订立石油合同同外国企业合作开采海洋石油资源，除法律、行政法规另有规定或者石油合同另有约定外，应当由石油合同中的外国企业一方（以下称外国合同者）投资进行勘探，负责勘探作业，并承担全部勘探风险；发现商业性油（气）田后，由外国合同者同中国海洋石油总公司双方投资合作开发，外国合同者并应负责开发作业和生产作业，直至中国海洋石油总公司按照石油合同规定在条件具备的情况下接替生产作业。外国合同者可以按照石油合同规定，从生产的石油中回收其投资和费用，并取得报酬。
第九条 外国合同者可以将其应得的石油和购买的石油运往国外，也可以依法将其回收的投资、利润和其他正当收益汇往国外。
第十条 参与合作开采海洋石油资源的中国企业、外国企业，都应当依法纳税。
第十一条 为执行石油合同所进口的设备和材料，按照国家规定给予减税、免税，或者给予税收方面的其他优惠。
第十二条 外国合同者开立外汇账户和办理其他外汇事宜，应当遵守《中华人民共和国外汇管理条例》和国家有关外汇管理的其他规定。
第十三条 石油合同可以约定石油作业所需的人员，作业者可以优先录用中国公民。
第十四条 外国合同者在执行石油合同从事开发、生产作业过程中，必须及时地、准确地向中国海洋石油总公司报告石油作业情况；完整地、准确地取得各项石油作业的数据、记录、样品、凭证和其他原始资料，并定期向中国海洋石油总公司提交必要的资料和样品以及技术、经济、财会、行政方面的各种报告。
第十五条 外国合同者为执行石油合同从事开发、生产作业，应当在中华人民共和国境内设立分支机构或者代表机构，并依法履行登记手续。
前款机构的住所地应当同中国海洋石油总公司共同商量确定。
第十六条 本条例第三条、第九条、第十条、第十一条、第十五条的规定，对向石油作业提供服务的外国承包者，类推适用。
第三章 石油作业
第十七条 作业者必须根据本条例和国家有关开采石油资源的规定，参照国际惯例，制定油（气）田总体开发方案和实施生产作业，以达到尽可能高的石油采收率。
第十八条 外国合同者为执行石油合同从事开发、生产作业，应当使用中华人民共和国境内现有的基地；如需设立新基地，必须位于中华人民共和国境内。
前款新基地的具体地点，以及在特殊情况下需要采取的其他措施，都必须经中国海洋石油总公司书面同意。
第十九条 中国海洋石油总公司有权派人参加外国作业者为执行石油合同而进行的总体设计和工程设计。
第二十条 外国合同者为执行石油合同，除租用第三方的设备外，按计划和预算所购置和建造的全部资产，当外国合同者的投资按照规定得到补偿后，其所有权属于中国海洋石油总公司，在合同期内，外国合同者仍然可以依据合同的规定使用这些资产。
第二十一条 为执行石油合同所取得的各项石油作业的数据、记录、样品、凭证和其他原始资料，其所有权属于中国海洋石油总公司。
前款数据、记录、样品、凭证和其他原始资料的使用和转让、赠与、交换、出售、公开发表以及运出、传送出中华人民共和国，都必须按照国家有关规定执行。
第二十二条 作业者和承包者在实施石油作业中，应当遵守中华人民共和国有关环境保护和安全方面的法律规定，并参照国际惯例进行作业，保护渔业资源和其他自然资源，防止对大气、海洋、河流、湖泊和陆地等环境的污染和损害。
第二十三条 石油合同区产出的石油，应当在中华人民共和国登陆，也可以在海上油（气）外输计量点运出。如需在中华人民共和国以外的地点登陆，必须经国务院指定的部门批准。
第四章 附 则
第二十四条 在合作开采海洋石油资源活动中，外国企业和中国企业间发生的争执，应当通过友好协商解决。通过协商不能解决的，由中华人民共和国仲裁机构进行调解、仲裁，也可以由合同双方协议在其他仲裁机构仲裁。
第二十五条 作业者、承包者违反本条例规定实施石油作业的，由国务院指定的部门依据职权责令限期改正，给予警告；在限期内不改正的，可以责令其停止实施石油作业。由此造成的一切经济损失，由责任方承担。
第二十六条 本条例所用的术语，其定义如下：
（一）“石油”是指蕴藏在地下的、正在采出的和已经采出的原油和天然气。
（二）“开采”是泛指石油的勘探、开发、生产和销售及其有关的活动。
（三）“石油合同”是指中国海洋石油总公司同外国企业为合作开采中华人民共和国海洋石油资源，依法订立的包括石油勘探、开发和生产的合同。
（四）“合同区”是指在石油合同中为合作开采石油资源以地理座标圈定的海域面积。
（五）“石油作业”是指为执行石油合同而进行的勘探、开发和生产作业及其有关的活动。
（六）“勘探作业”是指用地质、地球物理、地球化学和包括钻勘探井等各种方法寻找储藏石油的圈闭所做的全部工作，以及在已发现石油的圈闭上为确定它有无商业价值所做的钻评价井、可行性研究和编制油（气）田的总体开发方案等全部工作。
（七）“开发作业”是指从国务院指定的部门批准油（气）田的总体开发方案之日起，为实现石油生产所进行的设计、建造、安装、钻井工程等及其相应的研究工作，并包括商业性生产开始之前的生产活动。
（八）“生产作业”是指一个油（气）田从开始商业性生产之日起，为生产石油所进行的全部作业以及与其有关的活动，诸如采出、注入、增产、处理、贮运和提取等作业。
（九）“外国合同者”是指同中国海洋石油总公司签订石油合同的外国企业。外国企业可以是公司，也可以是公司集团。
（十）“作业者”是指按照石油合同的规定负责实施作业的实体。
（十一）“承包者”是指向作业者提供服务的实体。
第二十七条 本条例自公布之日起施行。
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
State Food and Drug Administration General Administration of Customs of the People’s Republic of China
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
(SFDA Decree No. 25)
The Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim), adopted by the State Food and Drug Administration, the General Administration of Customs of the People’s Republic of China and the General Administration of Sport of China, is hereby promulgated in the decree sequence number of the State Food and Drug Administration and shall come into force as of September 1, 2006.
Shao Mingli
Commissioner
State Food and Drug Administration
Mou Xinsheng
Minister
General Administration of Customs of the People’s Republic of China
Liu Peng
Minister
General Administration of Sport of China
July 28, 2006
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
Article 1 The Provisions are formulated with a view to standardizing the administration of import and export of anabolic agents and peptide hormones in accordance with the Drug Administration Law of the People’s Republic of China, Customs Law of People's Republic of China, Anti-doping Regulations and other relevant laws and administrative regulations.
Article 2 The State adopts license control on the import and export of anabolic agents and peptide hormones.
Article 3 The importer shall apply for the importation of anabolic agents and peptide hormones to the State Food and Drug Administration.
Article 4 For the importation of anabolic agents and peptide hormones for medical purpose, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Copy of the Import Drug License (or the Pharmaceutical Product License) (original or duplicate);
(4) Copy of the Drug Supply Certificate, Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importer; to import drug substance and intermediate preparations including preparations to be repackaged in China for their own needs, drug manufacturers shall submit copies of the Drug Manufacturing Certificate, Corporate Business License and Organization Code Certificate;
(5) Where holders of the Import Drug License (or the Pharmaceutical Product License) entrust other companies to export their drugs, they shall provide the authorization letter for export.
All copies mentioned above should be stamped with the official seal of the importer.
Article 5 For the importation of anabolic agents and peptide hormones for teaching and scientific research purposes, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Certificates of legitimate qualifications of users in China, calculation basis for the quantity of the drug in use and letter of guarantee issued by the user for legitimate use and management of the drug;
(4) Approval documents for relevant scientific research projects or approval documents of relevant competent authority;
(5) Where entrusted by users for importation, importers shall provide copies of the authorization agreement, the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importers.
All copies mentioned above should be stamped with the official seal of the importer.
Article 6 Where a enterprise in China entrusted by an overseas enterprise for contract manufacturing needs to import anabolic agents and peptide hormones, it shall provide materials required in Items (1), (3) and (5) of Paragraph 1 of Article 5, in addition, official documents to prove recorded by the local (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government.
All copies mentioned above should be stamped with the official seal of the importer.
Article 7 The State Food and Drug Administration shall decide whether or not to approve the import within 15 working days after receiving the application for import and the relevant materials. Where the application is approved, the State Food and Drug Administration shall issue the Import License for the drug; where the application is not approved, the State Food and Drug Administration shall give reasons in writing.
Article 8 The importer may declare to the customs of the ports where drug importation is permitted upon presenting the Import License for the drug issued by the State Food and Drug Administration. The customs shall clear the drug in the presence of the Import License for the drug.
The Drug Import Note is not required for import of anabolic agents and peptide hormones.
Article 9 To import anabolic agents and peptide hormones including those sold in China for the first time for medical purpose, the importer shall fill in the Import Drug Clearance Form timely after going through the import formalities and submit the following materials in duplicate to the (food and) drug regulatory department where the port of entry is located, upon presenting the original Import Drug License (or the Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug, to apply for the Notice of Import Drug Port Test:
(1) Copies of the Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the Import License for the drug;
(2) Copies of the Drug Manufacturing Certificate or Drug Supply Certificate, and Copy of the Business License for Enterprises as a Legal Person.
(3) Copy of the certificate of origin;
(4) Copy of the purchasing contract;
(5) Copies of packing list, bill of lading and freight invoice;
(6) Copy of the certificate of analysis;
(7) Format of drug insert sheet, package and label (except for drug substance and intermediate preparation);
All copies mentioned above should be stamped with the official seal of the importer.
Article 10 After checking the received Import Drug Clearance Form and relevant materials, the port (food and) drug regulatory department shall return the original Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug to the importer, and send the Notice of Import Drug Port Test, along with a copy of the dossier as prescribed in Article 9 of the Provisions, to the port drug testing institute on the same day.
After receiving the Notice of Import Drug Port Test, the port drug testing institute shall contact the importer within two working days and conduct sampling on the storage site. Upon the completion of the sampling, the mark “sampled” shall be stamped on the back of the first page of the original Import License for the drug, with the seal of sampling institute affixed.
Article 11 Anabolic agents and peptide hormones imported for teaching and research purposes or for the domestic manufacturing contracted by overseas enterprises are exempted from testing.
Article 12 The port (food and) drug regulatory department shall report timely to the State Food and Drug Administration in any of the following circumstances:
(1) The port (food and) drug regulatory department refuses to issue the Notice of Import Drug Port Test in accordance with the provisions in Article 17 of the Provisions for Import Drug (Decree No. 4 of the State Food and Drug Administration and the General Administration of Customs);
(2) The port (food and) drug testing institute refuses the sampling in accordance with the requirements in Article 25 of the Provisions for Import Drug.
The port (food and) drug regulatory department shall take mandatory administrative measures to seal up or seize all the imported drugs within the situations prescribed in the previous paragraph. It shall make the decision of allowing shipping back within seven days from the date of the seal-up or seizure, and inform the importer of applying for the Export License for the drug according to the export procedures for anabolic agents and peptide hormones prescribed in the Provisions and return all the import drugs to the original exporting country.
Where the importer fails to respond or make clear its intention to ship back the drugs within ten days after being informed of the decision, the sealed up or seized drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.
Article 13 For imported anabolic agents and peptide hormones out of specifications upon testing by the port drug testing institute, the importer shall provide a detailed report about the distribution and use of all the imported drugs to the port (food and) drug regulatory department where the importer is located within two days after receiving the Import Drug Test Report.
After receiving the Import Drug Test Report, the port (food and) drug regulatory departments shall take mandatory administrative measures to timely seal up or seize all the drugs and, within seven days, decide whether or not to place the case on file.
Where the importer fails to apply for a retesting within the specified timeline or the result of the retesting is still out of specifications, the port (food and) drug regulatory department shall make the decision of allowing shipping back and notify the importer to apply for the Export License for the drug according to export procedures for anabolic agents and peptide hormones prescribed in the Provisions to return all the imported drugs to the original exporting country. Where the importer fails to respond or make clear its intention to ship back the drugs within ten days from the date of receiving the decision, the drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.
Where the result of retesting is in compliance with the specifications, the port (food and) drug regulatory department shall remove the mandatory administrative measures of seal-up and seizure.
The port (food and) drug regulatory department shall handle the case according to the provisions in Paragraph 2, Paragraph 3 and Paragraph 4 of this Article and report the result to the State Food and Drug Administration, and, at the same time, notify the (food and) drug regulatory departments of provinces, autonomous regions and municipalities directly under the Central Government as well as other port (food and) drug regulatory departments.
Article 14 Where domestic drug manufacturers, distributors and medical institutions purchase imported anabolic agents and peptide hormones, the supplier shall provide copies of the Import Drug License (or Pharmaceutical Product License), the Import License for the drug and the Import Drug Test Report, and affix its official seal to the abovementioned copies.
Article 15 The exporter shall apply for exportation of anabolic agents and peptide hormones to the (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government, where it is located, and submit the following materials:
(1) Application Form for Drug Export;
(2) Original import permit (or its copy with notarization) provided by the drug regulatory authority of the importing country or region.
If the importing country or region has no license system in the importation of anabolic agents and peptide hormones, the exporter shall provide the official document (original) of the drug regulatory authority of the importing country or region to prove that the import of the drugs of this type is exempted from the import permit, along with one of the following documents:
a. Original official document (or its copy with notarization) granting import provided by the drug regulatory authority of the importing country or region;
b. Certificates of legitimate qualifications of importers and original supporting document (or its copy with notarization) proving legitimate use of the drug;
(3) Copy of the purchasing contract or order form (except for manufacturers that export their own products);
(4) Copy of the export contract or order form;
(5) Where the export drug is an approved one produced by a domestic manufacturer, the Drug Manufacturing Certificate and Business License for Enterprises as a Legal Person of the manufacturer and a copy of the approval document of the drug shall be provided;
Where the export drug is produced by a domestic enterprise under contract of an overseas enterprise, the exporter shall provide a copy of the official document to prove recorded by the local (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government.
(6) Copies of the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the exporter.
All copies mentioned above should be stamped with the official seal of the exporter.
Article 16 Where the drugs are to be shipped back in accordance with the requirements in Article 12 and Article 13 of the Provisions, the exporter shall provide the following materials to apply for the Export License for the drug:
(1) Documents proving the request for return of goods made by the original exporter of the exporting country;
(2) Import License for the drug.
Article 17 The (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government shall decide whether or not to approve the export within 15 working days after receiving the export application and relevant materials.
Where the application is approved, the regulatory department shall issue the Export License for the drug; where the application is not approved, the regulatory department shall give reasons in writing.
Where the Export License for the drug is applied for in accordance with the requirements in Article 16 of the Provisions, the issuing authority shall mark “return of the original goods” on the Export License for the drug.
Article 18 The exporter may go through the customs formalities upon presenting the Export License for the drug issued by the (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government. The customs shall clear the drug in the presence of the Export License for the drug.
Article 19 The importer and exporter shall provide one more sheet of customs declaration form and apply for sign-back of the sheet when going through the customs formalities. The customs shall stamp the “proof seal” on the sheet in the presence of the Import License for the drug and Export License for the drug. The customs shall charge the cost according to the relevant regulations for issuing certificates.
The importer and exporter shall return the first sheet of the Import License for the drug or Export License for the drug along with the customs declaration form with the seal of the customs, to the issuing regulatory department within one month after completing the import and export.
Where the importer or exporter conducts no relevant importation or exportation after obtaining the Import License for the drug and Export License for the drug, the importer or exporter shall return the original license to the issuing regulatory department within one month after expiration of the license.
Article 20 The validation of the Import License for the drug is one year; the validation of the Export License for the drug is no more than three months (valid within the calendar year).
“One license for one customs clearance” is implemented for the Import License for the drug and Export License for the drug. The license shall be used only once within the validation and its content shall not be altered. Where the import or export is postponed for some reasons, the importer or exporter may request for a new license once with the original one.
Article 21 Where the Import License for the drug or Export License for the drug is lost, the importer or exporter shall report the loss to the original issuing authority in writing immediately. After receiving the loss report, the original issuing authority shall notify the port customs and reissue the license if no harmful consequences are found through confirmation.
Article 22 The Import License for the drug and Export License for the drug are uniformly printed by the State Food and Drug Administration.
Article 23 Where anabolic agents and peptide hormones are imported or exported in the form of processing trade, the customs shall go through and supervise the clearance formalities upon presentation of the Import License for the drug or Export License for the drug. Those not exported for special reasons shall be transferred to and handled by the local (food and) drug regulatory department in accordance with relevant regulations, and the customs shall conduct the verification and cancellation procedures in the presence of relevant documents.
Article 24 Anabolic agents and peptide hormones entering or leaving between bonded zones, export processing zones, other special Customs controlling areas, Customs bonded and controlling areas, with overseas, or between the special Customs controlling areas and the Customs bonded and controlling areas are exempt from application for the Import License for the drug or Export License for the drug, and supervised by the Customs.
Import License for the drug shall be applied for anabolic agents and peptide hormones entering from bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas into other places in China.
Export License for the drug shall be applied for anabolic agents and peptide hormones entering bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas from other places of China.
Article 25 Where an individual carries or mails anabolic agents and peptide hormones, within a reasonable amount, into or out of China for medical needs, the customs shall clear the drugs in the presence of prescriptions of medical institutions in accordance with relevant regulations on prescriptions of the competent health department.
Article 26 Besides prescribed in the Provisions, the importation, port test, supervision and control of anabolic agents and peptide hormones for medical purpose are implemented with reference to requirements related to drug importation in the Provisions for Drug Importation.
Article 27 Anabolic agents and peptide hormones imported for medical purpose mentioned in the Provisions refer to the import anabolic agents and peptide hormones to be used for preparation production or to be marketed in China.
Importer refers to the importer specified on the Import License for the drug obtained in accordance with the Provisions.
Exporter refers to the exporter specified on the Export License for the drug obtained in accordance with the Provisions.
Article 28 These Provisions shall go into effect as of September 1, 2006. The Notice on Import and Export of Anabolic Agents and Peptide Hormones (Guo Shi Yao Jian An [2004] No. 474) issued by the State Food and Drug Administration on September 30, 2004 shall be annulled therefrom.
